Menu
Meet the Program Commitee for 2022!
Program Committee
-
Petra Doerr, PharmD, RPh • Director
European Directorate for the Quality of Medicines and Healthcare (EDQM), France -
Sini Eskola, MPharm, MS, MSc • Director Regulatory Affairs
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium -
Marco Greco, PhD • President
European Patients' Forum, Belgium -
Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands -
Niklas Hedberg, MPharm • Chair EUnetHTA Executive Board
Dental and Pharmaceutical Benefits Agency, TLV, Sweden -
Volker Liebenberg • Chief Medical Officer
Elypta, Sweden -
Alan Morrison, PhD • Vice President Regulatory Affairs Intl
MSD, United Kingdom -
Karen A Noonan, MA • Senior Vice President, Global Regulatory Policy
Association of Clinical Research Organizations (ACRO), United States -
Sibilia Quilici • Executive Director
Vaccines Europe, Belgium -
Tim Buchanan • Senior Director, Clinical Lead, Tau, Neurology Patient Value Unit
UCB Biopharma, Belgium -
Manuel Haas, PharmD, MSc • Executive Director - Regulatory Affairs Europe
MSD, United Kingdom -
Rebecca Stanbrook, RPh • Executive Director, Regulatory and Development Policy, Regulatory Affairs
Novartis, Switzerland -
Matt Popkin, PhD • Senior Director, CMC Excellence, Global Regulatory Affairs
GlaxoSmithKline, United Kingdom -
Diane Wilkinson, PhD, RPh • Executive Director, Global CMC Regulatory Affairs
AstraZeneca, United Kingdom -
Thomas Brookland, MSc • EU Data and AI Policy Lead
F. Hoffmann-La Roche Ltd., Switzerland -
Douglas Gregory • Senior Director, Government Affairs Strategy and Excellence
Bristol Myers Squibb, Belgium -
Ronnie Harprit Mundair • Regional Labelling Head - AfME, Canada and LATAM - Senior Director
Pfizer, United Kingdom -
Rodrigo Palacios, MBA • Regulatory Policy Lead
F. Hoffmann-La Roche, Switzerland -
Henrik K. Nielsen, PhD, MBA, MSc • Vice President
Novo Nordisk A/S, Denmark -
Isabelle Stoeckert, PharmD • VP. Head Regulatory Affairs Europe Middle East Africa PH
Bayer AG, Germany -
Álmath Máire Spooner, PhD, RPh • Director of Regulatory Policy and Intelligence
AbbVie, Ireland -
Raphael Van Eemeren • EU QPPV Director, Global Patient Safety
Amgen AB, Sweden -
Alison Cave, PhD • Chief Safety Officer
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom -
Patrice Verpillat, DrMed, MD, PhD, MPH • Head of Global Epidemiology
Merck Healthcare KGaA, Germany -
Rick Vreman • Patient Access Manager
Roche, Netherlands -
Nadege Le Roux, DrPH, PhD • Regulatory Policy Senior Director
Bristol Myers Squibb, Switzerland -
Andras Incze • Founder & CEO, Akceso Advisors AG, Switzerland
University Lecturer Healthcare Management, B-W State University, Germany, Switzerland -
Piers Mahon • Senior Principal and European Leader
Oncology Evidence Networks, IQVIA, United Kingdom -
Bettina Ryll • Member of the First EU Cancer Mission Board
MPNE, Vision Zero Cancer, Sweden